Helix BioPharma Corp.: Helix Biopharma Corp. Announces Appointment of Permanent CEO and Independent Board Members
RICHMOND HILL, ON / ACCESSWIRE / April 18, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology
Source: finanznachrichten.de